Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.

Young Bae Choi Ji Won Lee Ki Woong Sung Hong Hoe Koo Hee Jin Kim Keon Hee Yoo

Published in: Journal of Korean medical science (2019)

Although CC is not always necessary after allo-HSCT for non-malignant diseases, our data suggest that day 14 peripheral blood chimerism may predict outcomes in patients with non-malignant diseases who underwent BM/PBSC transplants.

Keyphrases

hematopoietic stem cell
peripheral blood
allogeneic hematopoietic stem cell transplantation
bone marrow
electronic health record
type diabetes
acute myeloid leukemia
adipose tissue
soft tissue
insulin resistance
weight loss
bone loss
bone regeneration
glycemic control